Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies (Q40933846)
Jump to navigation
Jump to search
scientific article published on August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies |
scientific article published on August 1999 |
Statements
1 reference
Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies (English)
1 reference
1 reference
1 reference
Micheletti F
1 reference
Formentin A
1 reference
Canella A
1 reference
Marastoni M
1 reference
Bazzaro M
1 reference
Tomatis R
1 reference
Traniello S
1 reference
1 August 1999
1 reference
1 reference
29
1 reference
8
1 reference
2579-2589
1 reference
Identifiers
1 reference
1 reference